Oxford Immunotec

oxford immunotec global plc is a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. the company's first product is the t-spot®.tb test, which is used to test for tuberculosis infection. the t-spot.tb test has been approved for sale in over 50 countries, including the united states, where it has received pre-market approval from the food and drug administration, europe, where it has obtained a ce mark, as well as japan and china. the t-spot.cmv test is the company's second product and the first in a series of products intended for the transplantation market. overall, the company has seven active development programs, each of which leverages our t cell, b cell and innate immune measuring technology. the company is headquartered near oxford, u.k. and in marlborough, mass. additional information can be found at www.oxfordimmunotec.com. t-spot and the oxford immunotec logo are trademar